A proposed federal rule aims to expand Medicare and Medicaid coverage for GLP-1 weight loss drugs, targeting the rising obesity rates in the U.S. Expanding access to these medications could benefit millions of Americans, but faces potential challenges and costs.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing